Literature DB >> 25167221

GPER-1 and estrogen receptor-β ligands modulate aldosterone synthesis.

Brasilina Caroccia1, Teresa M Seccia, Abril Gonzalez Campos, Francesca Gioco, Maniselvan Kuppusamy, Giulio Ceolotto, Eugenia Guerzoni, Francesca Simonato, Sara Mareso, Livia Lenzini, Ambrogio Fassina, Gian Paolo Rossi.   

Abstract

Fertile women have lower blood pressure and cardiovascular risk than age-matched men, which suggests that estrogens exert cardiovascular protective effects. However, whether 17 β-estradiol (E2) blunts aldosterone secretion, and thereby affects the gender dimorphism of blood pressure, is unknown. We therefore sought for the estrogen receptor (ER) subtypes in human adrenocortical tissues ex vivo by performing gene and protein expression studies. We also investigated the effect of E2 on aldosterone synthesis and the involved receptors through in vitro functional experiments in the adrenocortical cells HAC15. We found that in the human adrenal cortex and aldosterone-producing adenoma cells, the most expressed ERs were the ERβ and the G protein-coupled receptor-1 (GPER-1), respectively. After selective ERβ blockade, E2 (10 nmol/L) markedly increased both the expression of aldosterone synthase and the production of aldosterone (+5- to 7-fold vs baseline, P < .001). Under the same condition, the GPER-1 receptor agonist 1-[4-(6-bromo-benzo (1, 3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c] quinolin-8-yl]-ethanone (G-1) (10 nmol/L) mimicked this effect, which was abrogated by cotreatment with either the GPER-1 receptor antagonist (3aS*,4R*,9bR*)-4-(6-Bro-mo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinoline (G-15), or a selective protein kinase A inhibitor 8-Bromo-2-monobutyryladenosine-3,5-cyclic mono-phosphorothioate, Rp-isomer. Silencing of the ERβ significantly raised aldosterone synthase expression and aldosterone production. Conversely, silencing of the GPER-1 lowered aldosterone synthase gene and protein expression. Moreover, it blunted the stimulatory effect of E2 on aldosterone synthase that was seen during ERβ blockade. These results support the conclusion that in humans, E2 inhibits aldosterone synthesis by acting via ERβ. Pharmacologic disinhibition of ERβ unmasks a potent secretagogue effect of E2 that involves GPER-1 and protein kinase A signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25167221     DOI: 10.1210/en.2014-1416

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  Aging and Adrenal Aldosterone Production.

Authors:  Kazutaka Nanba; Anand Vaidya; William E Rainey
Journal:  Hypertension       Date:  2017-12-11       Impact factor: 10.190

3.  Biological Sex Modulates the Adrenal and Blood Pressure Responses to Angiotensin II.

Authors:  Mohammad Zaki Shukri; Jia Wei Tan; Worapaka Manosroi; Luminita H Pojoga; Alicia Rivera; Jonathan S Williams; Ellen W Seely; Gail K Adler; Iris Z Jaffe; Richard H Karas; Gordon H Williams; Jose R Romero
Journal:  Hypertension       Date:  2018-04-23       Impact factor: 10.190

4.  The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.

Authors:  Worapaka Manosroi; Jia Wei Tan; Chevon M Rariy; Bei Sun; Mark O Goodarzi; Aditi R Saxena; Jonathan S Williams; Luminita H Pojoga; Jessica Lasky-Su; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der I Chen; Anny H Xiang; Willa A Hsueh; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Ellen W Seely
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

Review 5.  The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease.

Authors:  Ana P Davel; Imran J Anwar; Iris Z Jaffe
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

Review 6.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

Review 7.  Female Sex, a Major Risk Factor for Salt-Sensitive Hypertension.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Curr Hypertens Rep       Date:  2020-10-21       Impact factor: 5.369

8.  Pressure regulated basis for gene transcription by delta-cell micro-compliance modeled in silico: Biphenyl, bisphenol and small molecule ligand models of cell contraction-expansion.

Authors:  Hemant Sarin
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

Review 9.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

10.  Obesity and the diagnostic accuracy for primary aldosteronism.

Authors:  Amit Tirosh; Fady Hannah-Shmouni; Charalampos Lyssikatos; Elena Belyavskaya; Mihail Zilbermint; Smita B Abraham; Maya B Lodish; Constantine A Stratakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-13       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.